Royal Bank of Canada reissued their sector perform rating on shares of SelectQuote (NYSE:SLQT – Free Report) in a research report report published on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $4.00 target price on the stock.
Separately, Craig Hallum started coverage on shares of SelectQuote in a report on Monday, September 30th. They issued a “buy” rating and a $4.50 target price for the company.
Get Our Latest Stock Analysis on SLQT
SelectQuote Stock Down 1.0 %
SelectQuote (NYSE:SLQT – Get Free Report) last issued its quarterly earnings results on Friday, September 13th. The company reported ($0.18) earnings per share for the quarter. The company had revenue of $307.21 million for the quarter. SelectQuote had a negative net margin of 2.58% and a negative return on equity of 10.37%. On average, research analysts forecast that SelectQuote will post -0.16 EPS for the current fiscal year.
Institutional Investors Weigh In On SelectQuote
Several institutional investors have recently modified their holdings of SLQT. Jacobs Levy Equity Management Inc. lifted its stake in SelectQuote by 229.3% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,161,593 shares of the company’s stock valued at $2,323,000 after acquiring an additional 808,850 shares during the period. Panagora Asset Management Inc. lifted its position in SelectQuote by 85.5% during the second quarter. Panagora Asset Management Inc. now owns 410,009 shares of the company’s stock valued at $1,132,000 after purchasing an additional 189,029 shares during the period. Headlands Technologies LLC bought a new position in SelectQuote during the first quarter valued at approximately $36,000. Bank of New York Mellon Corp boosted its holdings in SelectQuote by 14.1% in the second quarter. Bank of New York Mellon Corp now owns 472,849 shares of the company’s stock worth $1,305,000 after purchasing an additional 58,481 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in SelectQuote by 18.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,414 shares of the company’s stock worth $83,000 after purchasing an additional 6,555 shares during the period. 34.59% of the stock is owned by hedge funds and other institutional investors.
SelectQuote Company Profile
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Articles
- Five stocks we like better than SelectQuote
- What is the Australian Securities Exchange (ASX)
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Which Wall Street Analysts are the Most Accurate?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What is a buyback in stocks? A comprehensive guide for investors
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.